Loma Linda, CALIFORNIA2 Active Studies

B-Cell Acute Lymphoblastic Leukemia Clinical Trials in Loma Linda, CALIFORNIA

Find 2 actively recruiting b-cell acute lymphoblastic leukemia clinical trials in Loma Linda, CALIFORNIA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
5,219
Enrolling

Recruiting B-Cell Acute Lymphoblastic Leukemia Studies in Loma Linda

About B-Cell Acute Lymphoblastic Leukemia Clinical Trials in Loma Linda

B-cell acute lymphoblastic leukemia (B-ALL) is a fast-growing cancer of the B-type lymphocyte white blood cells. It is the most common childhood cancer but can also occur in adults. Treatment includes chemotherapy, targeted therapy, and CAR-T cell therapy.

There are currently 2 b-cell acute lymphoblastic leukemia clinical trials recruiting participants in Loma Linda, CALIFORNIA. These studies are seeking a combined 5,219 participants. Research is being sponsored by Children's Oncology Group, National Cancer Institute (NCI). Clinical trial participation is free and participants receive study-related medical care at no cost.

B-Cell Acute Lymphoblastic Leukemia Clinical Trials in Loma Linda — FAQ

Are there b-cell acute lymphoblastic leukemia clinical trials in Loma Linda?

Yes, there are 2 b-cell acute lymphoblastic leukemia clinical trials currently recruiting in Loma Linda, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Loma Linda?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Loma Linda research site will contact you about next steps.

Are clinical trials in Loma Linda free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Loma Linda studies also compensate for your time and travel.

What b-cell acute lymphoblastic leukemia treatments are being tested?

The 2 active trials in Loma Linda are testing new therapies including novel drugs, biologics, and treatment approaches for b-cell acute lymphoblastic leukemia.

Data updated March 2, 2026 from ClinicalTrials.gov